Clinical analysis and nursing intervention of intravenous thrombolysis with urokinase in patients with acute myocardial infarction
10.3969/j.issn.1005-1678.2017.10.160
- VernacularTitle:尿激酶静脉溶栓治疗急性心肌梗死的临床分析及护理干预
- Author:
mei Jian CHEN
1
;
fang Li XIAO
Author Information
1. 浙江省医疗健康集团杭州医院 急诊科
- Keywords:
urokinase;
intravenous thrombolytic therapy;
acute myocardial infarction;
clinical analysis;
nursing intervention
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(10):360-361
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate and analyze the clinical analysis and nursing intervention of intravenous thrombolysis with urokinase in the treatment of acute myocardial infarction. Methods 40 patients with acute myocardial infarction treated in Hangzhou Hospital of Zhejiang Medical and Health Group from February 2015 to August 2016 were selected and randomly divided into the control group and the experimental group, with 20 patients in each group. The control group received routine treatment, intravenous drip of nitroglycerin and subcutaneous injection of low molecular weight heparin. On this basis, the experimental group was given urokinase intravenous thrombolysis treatment. Two groups of patients were given reasonable nursing intervention measures to improve the quality of care. The therapeutic effects of the experimental group and the control group were compared and analyzed. Results After the corresponding treatment, the effective number of patients in the experimental group was 19 cases (95.0%). In the control group, the effective number of treatment was 13 cases (65.0%). The effective rate of treatment in the experimental group was significantly higher than that in the control group, with statistical difference (P<0.05). The remission time of the chest pain in the control group was (15.32±7.21) h, and the remission time of the chest pain in the experimental group was (2.72±0.67) h. The improvement time of chest pain in the experimental group was significantly shorter than that in the control group, with statistical difference (P<0.05). In addition, the probability of complications in the experimental group was 10%, which was significantly lower than that in the control group (40.0%), and there was a statistical difference (P<0.05). Conclusion Intravenous thrombolysis with urokinase in treatment of acute myocardial infarction treatment effect is ideal, can improve clinical symptoms in a large extent, improve the efficiency of treatment, the treatment of high safety, with the further promotion of the clinical significance.
